CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
the study drugs fostamatinib and paclitaxel. This study tests different doses of the drugs to see which doses are safest in people with ovaria cancer...
Phase 1
Baltimore, Maryland, United States and 2 other locations
bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...
Phase 3
Silver Spring, Maryland, United States and 22 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Towson, Maryland, United States and 213 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Baltimore, Maryland, United States and 125 other locations
(CAR) T cells developed by Precigen, Inc.) in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has...
Phase 1
Bethesda, Maryland, United States and 1 other location
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Glenn Dale, Maryland, United States and 46 other locations
clinical activity, pharmacokinetics (PK), and pharmacodynamics (PD) of ZN-c3 in combination with niraparib in subjects with platinum-resistant ovarian...
Phase 1, Phase 2
Fairfax, Virginia, United States and 18 other locations
of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian...
Phase 3
Silver Spring, Maryland, United States and 93 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Baltimore, Maryland, United States and 176 other locations
Phase 1 trial to study the safety, pharmacokinetic and Preliminary Efficacy of STRO-002 in combination with Bevacizumab.
Phase 1
Fairfax, Virginia, United States and 5 other locations
Clinical trials
Research sites
Resources
Legal